Piperlongumine overcomes imatinib resistance by inducing proteasome inhibition in chronic myelogenous leukemia cells.
Lan X, Hu M, Jiang L, Wang J, Meng Y, Chen X, Liu A, Ding W, Zhang H, Zhou H, Liu B, Peng G, Liao S, Chen X, Liu J, Shi X.
Lan X, et al. Among authors: jiang l.
J Ethnopharmacol. 2023 Jan 30;301:115815. doi: 10.1016/j.jep.2022.115815. Epub 2022 Oct 8.
J Ethnopharmacol. 2023.
PMID: 36220508
Free article.